Our Team
Patricia (Penny) K. Sneed, MD, FACR
Professor
Clinical Services Director at Parnassus and Vice-Chair,
Department of Radiation Oncology
Mother, grandmother, quilter
Meet Dr. Sneed
Dr. Sneed is a senior Radiation Oncologist at UCSF who specializes in radiotherapy and radiosurgery for brain metastases and various primary brain tumors. She earned a summa cum laude undergraduate degree in Electrical Engineering from the University of Missouri in 1976, graduated from Stanford Medical School in 1981, and did her Radiation Oncology residency and a one-year research fellowship at UCSF, joining the faculty in 1986. She officially retired as of July 2018 and then returned in August 2018 as a recalled faculty member, working 43% time. She has tremendous expertise in Gamma Knife radiosurgery–dating back to January 1992–for brain metastases, meningiomas, schwannomas, pituitary adenomas, arteriovenous malformations, trigeminal neuralgia, and other conditions. She greatly enjoys interacting with patients and their families and working with multidisciplinary colleagues and trainees.
Education
|
Professional Experience
|
Awards & Honors
|
ResearchNIH: https://www.ncbi.nlm.nih.gov/myncbi/penny.sneed.1/bibliography/public/ Significant Research Highlights:PMID 31835173: UCSF was a major contributor of cases to this large multi-institutional study describing results of volume-staged radiosurgery for large arteriovenous malformations. PMID 31785436: UCSF has extensive experience with radiosurgery for brain metastases. This paper describes results in patients with ten or more brain metastases. PMID 31168670: Dr. Sneed and Dr. McDermott have the largest published experience showing the success of radiotherapy in controlling multiply recurrent epidermoid cysts. PMID 27367240: UCSF has a long experience with brain brachytherapy. This paper reports results of permanent brachytherapy for 95 large or recurrent brain metastases. PMID 25978710: Dr. Sneed spearheaded this study of the incidence, time course, and risk factors for overall adverse radiation effect (ARE) and symptomatic ARE after stereotactic radiosurgery for 2200 brain metastases in 435 evaluable patients. |